• Drug Testing, Presumptive (Drug Screen), Urine
  • Coagulation Factor VII Activity Assay, Plasma
  • Von Hippel-Lindau (VHL) Gene Mutation Analysis
  • Chlordiazepoxide, Serum
  • Lysosomal Acid Lipase, Enzyme Activity
  • Salivary Gland Tumor, MYB (6q23) Rearrangement by FISH
  • Interferon-γ Receptor (IFNGR1) Deficiency
  • CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • Biopsy, Bile Duct
  • Cancer Antigen (CA) 72-4
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MLH1 Hypermethylation (Promoter Methylation) Analysis, Blood
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MLH1 Hypermethylation (Promoter Methylation) Analysis, Blood
Medical Test

Diseases (2)
Access to MLH1 Hypermethylation (Promoter Methylation) Analysis, Blood is restricted.